Handelsbanken Fonder
BCYC

Handelsbanken Fonder’s Bicycle Therapeutics BCYC Stock Holding History

Handelsbanken Fonder’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150,000
Closed -$1.16M – 1505
2025
Q3 		$1.16M Sell
150,000
-50,000
-25% -$377K ﹤0.01% 946
2025
Q2 		$1.39M Sell
200,000
-15,900
-7% -$127K ﹤0.01% 805
2025
Q1 		$1.83M Hold
215,900
– – 0.01% 683
2024
Q4 		$3.02M Sell
215,900
-2,800
-1% -$60K 0.01% 548
2024
Q3 		$4.95M Buy
218,700
+5,200
+2% +$120K 0.02% 438
2024
Q2 		$4.32M Buy
213,500
+33,700
+19% +$761K 0.02% 438
2024
Q1 		$4.48M Buy
179,800
+40,000
+29% +$850K 0.02% 463
2023
Q4 		$2.53M Buy
139,800
+5,300
+4% +$87.7K 0.01% 512
2023
Q3 		$2.7M Hold
134,500
– – 0.02% 500
2023
Q2 		$3.43M Buy
134,500
+2,700
+2% +$62.7K 0.02% 463
2023
Q1 		$2.8M Hold
131,800
– – 0.02% 486
2022
Q4 		$3.9M Buy
131,800
+1,800
+1% +$48.3K 0.02% 439
2022
Q3 		$3.02M Hold
130,000
– – 0.02% 472
2022
Q2 		$2.18M Hold
130,000
– – 0.01% 518
2022
Q1 		$5.7M Buy
130,000
+50,000
+63% +$2.33M 0.03% 436
2021
Q4 		$4.87M Buy
+80,000
New +$4.41M 0.02% 477

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
GP
GSK plc London $599M AUM
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Handelsbanken Fonder's BCYC Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Bicycle Therapeutics (BCYC) in Q4 2025, closing a stake of 150,000 shares — an estimated $1.16M sold.

Handelsbanken Fonder first reported a position in BCYC in Q4 2021 and held it in 16 quarters. The position peaked at $5.7M in Q1 2022. 109 funds tracked by Wall St. Rank hold BCYC as of Q4 2025.

  • Handelsbanken Fonder reported no remaining Bicycle Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 150,000 Bicycle Therapeutics shares in Q4 2025, an estimated $1.16M.
  • Handelsbanken Fonder first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 16 quarters.
  • Handelsbanken Fonder's Bicycle Therapeutics position peaked at $5.7M in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.